Therapy for bronchopulmonary dysplasia in premature infants focuses on reducing the effects of oxygen toxicity and mechanical ventilation

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.21, Iss.7, 2005-07, pp. : 11-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bronchopulmonary Dysplasia in Preterm Infants: Pathophysiology and Management Strategies

By Carl T. D’Angio   William M. Maniscalco  

Pediatric Drugs, Vol. 6, Iss. 5, 2004-01 ,pp. : 303-330

Adis International

Access to resources Recommend Favorite

Management of Bronchopulmonary Dysplasia in Infants: Guidelines for Corticosteroid Use

By Grier David G.   Halliday Henry L.  

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 15-29

Adis International

Access to resources Recommend Favorite

Vitamin A in Prevention of Bronchopulmonary Dysplasia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 21, 2012-05 ,pp. : 3101-3113

Bentham Science Publishers

Access to resources Recommend Favorite

Fluconazole Pharmacokinetics and Safety in Premature Infants

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4617-4620

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Open Lung Ventilation on Respiratory Mechanics and Haemodynamics in Atelectatic Infants after Cardiopulmonary Bypass

By Cui Q   Zhou H   Zhao R   Liu J   Yang X   Zhu H   Zheng Q   Gu C   Yi D  

The Journal of International Medical Research, Vol. 37, Iss. 1, 2009-01 ,pp. : 113-120

Field House Publishing

Access to resources Recommend Favorite